Impact of a pharmacy-led medication adherence program for disease-modifying therapies (DMTs) in patients with Multiple Sclerosis (MS)

Background: Adherence to DMTs in the treatment of MS has shown to improve clinical outcomes by reducing the likelihood of relapse and the number of hospitalizations and emergency room visits, but it is often difficult to achieve and even more challenging to sustain for many patients. PerformRx ℠ is a pharmacy benefit manager dedicated to innovation and providing the most efficacious outcomes. The Clinical Outcomes and Therapeutic Optimization Department carries out a variety of drug therapy management programs tailored to the needs of the patients and providers, including medication adh erence programs for high-cost, high-impact medications like DMTs.
Source: Research in Social and Administrative Pharmacy - Category: Pharmaceuticals Authors: Source Type: research